WFH NETWORK

CDC Webinar: Joint Guidelines on the Diagnosis and Management of VWD

 
Details

Year: 2021

Language: English

Author(s): Jean Grow, Nathan Connell, Angela Weyand

Date: February 25, 2021

Access Webinar
Additional Information

On February 25th, 2021 the CDC presented this one-hour webinar on the ASH ISTH NHF WFH 2021 Guidelines on the Diagnosis and Management of von Willebrand Disease (VWD) as part of the Public Health Webinar Series on Blood Disorders.

Jean Grow, PhD, Nathan Connell, MD, MPH, and Angela Weyand, MD, guideline development panelists and experts on living with, diagnosing and managing VWD discussed how the guidelines were developed, why they are important for people with VWD, and some of the highlights for their implementation in the diagnosis and management of the most common inherited bleeding disorder.

Their presentations were followed by an extensive and informative Q&A session.

To view a pdf of the slides from the webinar, click on the icon below.

pdf_icon

 

Source: U.S. Centers for Disease Control & Prevention, February 2021.

 

The WFH does not engage in the practice of medicine and under no circumstances recommends particular treatment for specific individuals. For diagnosis or consultation on a specific medical problem, the WFH recommends that you contact your physician or local treatment centre. Before administering any products, the WFH urges patients to check dosages with a physician or hemophilia centre staff, and to consult the pharmaceutical company’s printed instructions.

The WFH does not promote any particular pharmaceutical product and any mention of any commercial brand in this presentation is strictly for educational purposes.